| Management |
| Jean-Patrick Voisin, MBA C.E.O. |
| Luc Lenglet, ENS C.E.O. Magnisense France |
| Petr Nikitin, PhD Chief Scientific Officer |
| Senior Advisory Board |
| Dominique Bellet, PharmD, MD, PhD |
| Jean-Claude Mongrenier, PharmD, MBA |
| Christian Policard, Docteur in Biochemistry |
| Partners |
| Russian Academy of Sciences |
| University of Paris 13 |
Jean-Patrick Voisin, MBA
C.E.O.
|
Our History
May 2003: Magnisense created by Baring Vostok Capital Partners and private investors.
2003 – 2006: Technical development carried out jointly by Petr Nikitin’s team in Moscow and Bertin Technologies in France for engineering.
June 2006: Second round of financing.
November 2006: Business development teams created both in Europe and in the USA.
September 2007: New patent application filed for a multiparametric magnetic immunoassay, MIAplex™.
February 2008: Creation of Magnisense Biological Development Laboratory in Dardilly, France.
December 2008: Third round of financing.
2008 – 2009: Several external validation studies on-going with leading human and veterinary IVD players.